Get the Stockscreener App
340.53
0.61%
2.05
Bio Rad Laboratories Inc Stock (BIO) Latest News
Citigroup Inc. Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Thrivent Financial for Lutherans Buys 3,675 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
(BIO.B) Technical Data - Stock Traders Daily
The Manufacturers Life Insurance Company Raises Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Position Cut by Charles Schwab Investment Management Inc. - MarketBeat
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Yahoo Finance
Cell Counting Market to Evolve at a Modest 6.8% CAGR through 2031 | SkyQuest Technology - Benzinga
BIO.B (Bio-Rad Laboratories) Profitability Rank : 7 (As of Sep. 2024) - GuruFocus.com
Microfluidics for Healthcare Application Market to grow by USD 110.2 Billion from 2024-2028, driven by compact microfluidic devices and AI-powered evolutionTechnavio - The Malaysian Reserve
Electrophoresis Reagents Market Size, Trends Analysis 2031 - openPR
Next Generation Sequencing (NGS) Market Expected to Reach USD - openPR
Bio-Rad Laboratories (FRA:BUWA) 3-Year Revenue Growth Rate : 2.70% (As of Sep. 2024) - GuruFocus.com
Food Safety Testing Market to Grow by USD 10.51 Billion (2024-2028), Government Agency Involvement Boosts Growth, Report on AI Redefining Market LandscapeTechnavio - The Malaysian Reserve
Bio-Rad Laboratories (STU:BUWA) Peter Lynch Fair Value : N/A (As of Nov. 26, 2024) - GuruFocus.com
DRW Securities LLC Makes New $1.59 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Massachusetts Financial Services Co. MA Has $18.12 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Custom Antibody Service Market Generated Opportunities, - openPR
BIO (Bio-Rad Laboratories) 3-Year Book Growth Rate : -2.50% (As of Sep. 2024) - GuruFocus.com
Why Bio-Rad Laboratories Is Overvalued: A Fundamental And DCF Analysis (NYSE:BIO) - Seeking Alpha
Is Bio-Rad Laboratories, Inc. (NYSE:BIO) Potentially Undervalued? - Simply Wall St
In Vitro Diagnostics (IVD) Quality Control Global Market Report - openPR
What is Zacks Research's Forecast for BIO FY2024 Earnings? - MarketBeat
Sexually Transmitted Disease (STD) Testing Market Size, Growth - openPR
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory - MSN
Westfield Capital Management Co. LP Buys 9,584 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Mutual of America Capital Management LLC Buys 7,777 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by CIBC Asset Management Inc - MarketBeat
Zacks Research Analysts Lower Earnings Estimates for BIO - MarketBeat
Horseradish Peroxidase Market Company Profiles, Segments, - openPR
Metagenomics Market Is Booming Worldwide 2024-2031 | Bio-Rad - openPR
Cancer Monoclonal Antibodies Market Overall Study Report - openPR
Legionella Testing Market Report 2022Non-Invasive - openPR
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference - BioSpace
Thompson Siegel & Walmsley LLC Sells 83,227 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
One Step RT-qPCR Kits Market Key Players AnalysisTakara Bio - openPR
Natixis Advisors LLC Has $13.83 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Leukemia Screening Market Future Business Opportunities - openPR
Custom Antibody Services Market Report: Detailed Insights - openPR
Cell Signaling Market: Opportunities, Challenges, and Growth - openPR
Electrophoresis Reagents Market: Company Profiles, Segment - openPR
Hematology Testing Products Market Statistical Forecast - openPR
Biological Multiplex Assays Market to Witness Significant - openPR
IVD quality control Market Share, Trends, Top Players, Segments - openPR
Biochips Market Opportunities and Trends With Leading Key - openPR
DNA Extraction Kits Market Is Booming Worldwide 2024-2031 | - openPR
Cell Viability Assays Market Opportunities and Trends - openPR
DNA Sequencing Market Enhanced Profitability, And Supply - openPR
Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - GlobeNewswire Inc.
Mawer Investment Management Ltd. Boosts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Protein Chip Market Growth, Industry Development and Forecast - openPR
Genomic Biomarker Market 2024 Opportunity, Challenge, - openPR
Laboratory Mixer Market Strong Industry Growth, Business - openPR
Research Antibodies Market Report Outlines Revenue Share, SWOT - openPR
Genomic Biomarker Market Dynamics and Forecast Comprehensive - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
StarBright Yellow 561: A reliable alternative to PE-tandem dyes - News-Medical.Net
Clinical Diagnostics Market to Reach $ 110.0 Billion by 2031 | - openPR
Multiplexed Diagnostics Market Share, Trends, Top Players, - openPR
Apoptosis Assays Market Analysis By Top KeyplayersMerck, - openPR
High-throughput Screening Technology Market Size and Regional An - News Channel Nebraska
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Boosted by Principal Financial Group Inc. - MarketBeat
Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges - BioProcess Insider
Short Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Declines By 20.8% - MarketBeat
Chromatography Systems Market Industry Detailed Exploration, - openPR
VAN ECK ASSOCIATES CORP's Strategic Acquisition in Bio-Rad Labor - GuruFocus.com
Chiral Chromatography Columns Market Overall Study Report - openPR
Dental Services Market Overall Study Report 2024-2032 | Agilent - openPR
Genomics Market Overall Study Report 2024-2032 | Agilent - openPR
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):